ピンドロール
参考資料

1 2  Drugs.com International brand names for pindolol Archived 2017-10-01 at the Wayback Machine. Page accessed Sept 4, 2015
1 2  Wong, GW; Boyda, HN; Wright, JM (Nov 2014). “Blood pressure lowering efficacy of partial agonist beta blocker monotherapy for primary hypertension”. Cochrane Database Syst Rev 11 (11):  CD007450. doi:10.1002/14651858.CD007450.pub2. PMC 6486122. PMID 25427719. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486122/.
1 2  “The use of pindolol to potentiate antidepressant medication”. J Clin Psychiatry 59 Suppl 5:  16–23; discussion 24–5. (1998). PMID 9635544.
1 2 3 4  “Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research”. CNS Drugs 27 (9):  703–16. (2013). doi:10.1007/s40263-013-0071-0. PMID 23757185.
1 2 3  “Is pindolol augmentation effective in depressed patients resistant to selective serotonin reuptake inhibitors? A systematic review and meta-analysis”. Hum Psychopharmacol 30 (3):  132–42. (2015). doi:10.1002/hup.2465. PMID 25689398.
1 2  “カルビスケン錠５ｍｇ 添付文書”. www.info.pmda.go.jp.   PMDA. 2021年4月19日閲覧。
↑  “Archived copy”. 2011年9月27日時点のオリジナルよりアーカイブ。2010年8月15日閲覧。
1 2  “PDSP Ki Database”. Psychoactive Drug Screening Program (PDSP).   University of North Carolina at Chapel Hill and the United States National Institute of Mental Health. 14 August 2017閲覧。
↑  “The main features of central 5-HT1 receptors”. Neuropsychopharmacology 3 (5–6):  349–60. (1990). PMID 2078271.
1 2 3  “Human serotonin 1D receptor is encoded by a subfamily of two distinct genes: 5-HT1D alpha and 5-HT1D beta”. Proc. Natl. Acad. Sci. U.S.A. 89 (8):  3630–4. (1992). Bibcode: 1992PNAS...89.3630W. doi:10.1073/pnas.89.8.3630. PMC 48922. PMID 1565658. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC48922/.
1 2 3  “Indoloxypropanolamine analogues as 5-HT(1A) receptor antagonists”. Bioorg. Med. Chem. Lett. 17 (20):  5600–4. (2007). doi:10.1016/j.bmcl.2007.07.086. PMID 17804228.
↑  “Molecular biology of 5-HT receptors”. Neuropharmacology 33 (3–4):  275–317. (1994). doi:10.1016/0028-3908(94)90059-0. PMID 7984267.
↑  “Human gene S31 encodes the pharmacologically defined serotonin 5-hydroxytryptamine1E receptor”. Mol. Pharmacol. 42 (2):  180–5. (1992). PMID 1513320.
↑  “Cloning of another human serotonin receptor (5-HT1F): a fifth 5-HT1 receptor subtype coupled to the inhibition of adenylate cyclase”. Proc. Natl. Acad. Sci. U.S.A. 90 (2):  408–12. (1993). Bibcode: 1993PNAS...90..408A. doi:10.1073/pnas.90.2.408. PMC 45671. PMID 8380639. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC45671/.
1 2 3  “Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors”. Naunyn Schmiedebergs Arch. Pharmacol. 370 (2):  114–23. (2004). doi:10.1007/s00210-004-0951-4. PMID 15322733.
1 2 3 4  “The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons”. Eur. J. Pharmacol. 325 (2–3):  145–53. (1997). doi:10.1016/s0014-2999(97)00131-3. PMID 9163561.
↑  “Characterisation of 5-HT3 recognition sites in membranes of NG 108-15 neuroblastoma-glioma cells with [3H]ICS 205-930”. Naunyn Schmiedebergs Arch. Pharmacol. 337 (5):  493–9. (1988). doi:10.1007/bf00182721. PMID 3412489.
↑  “Identification of serotonin 5-HT3 recognition sites in membranes of N1E-115 neuroblastoma cells by radioligand binding”. Mol. Pharmacol. 33 (3):  303–9. (1988). PMID 3352595.
↑  “Cloning and characterization of the rat 5-HT5B receptor. Evidence that the 5-HT5B receptor couples to a G protein in mammalian cell membranes”. FEBS Lett. 333 (1–2):  25–31. (1993). doi:10.1016/0014-5793(93)80368-5. PMID 8224165.
↑  “Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase”. Mol. Pharmacol. 44 (2):  229–36. (1993). PMID 8394987.
↑  “Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase”. J. Biol. Chem. 268 (31):  23422–6. (1993). doi:10.1016/S0021-9258(19)49479-9. PMID 8226867.
↑  “Cloning, expression and pharmacology of a truncated splice variant of the human 5-HT7 receptor (h5-HT7b)”. Br. J. Pharmacol. 122 (1):  126–32. (1997). doi:10.1038/sj.bjp.0701336. PMC 1564895. PMID 9298538. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1564895/.
1 2 3  “Comparative pharmacology of human beta-adrenergic receptor subtypes--characterization of stably transfected receptors in CHO cells”. Naunyn Schmiedebergs Arch. Pharmacol. 369 (2):  151–9. (2004). doi:10.1007/s00210-003-0860-y. PMID 14730417.
↑  “Characterization of (125)I-IABN, a novel azabicyclononane benzamide selective for D2-like dopamine receptors”. Synapse 38 (4):  438–49. (2000). doi:10.1002/1098-2396(20001215)38:4<438::AID-SYN9>3.0.CO;2-5. PMID 11044891.
↑  Wiysonge, Charles Shey; Volmink, Jimmy; Opie, Lionel H (2007). “Beta-blockers and the treatment of hypertension: it is time to move on”. Cardiovascular Journal of Africa 18 (6):  351–352. ISSN 1995-1892. PMC 4170499. PMID 18092107. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170499/.
↑  “Pindolol augmentation of antidepressant response”. Curr Drug Targets 7 (2):  139–47. (2006). doi:10.2174/138945006775515446. PMID 16475955.
↑  "Discovery and Development of Major Drugs. Chapter 2 in Pharmaceutical Innovation: Revolutionizing Human Health. Volume 2 of Chemical Heritage Foundation series in innovation and entrepreneurship. Eds Ralph Landau, Basil Achilladelis, Alexander Scriabine. Chemical Heritage Foundation, 1999. ISBN 9780941901215 p 185
↑  “カルビスケン錠5mg インタビューフォーム”.   PMDA. 2021年4月19日閲覧。
↑  Fernandes, E; Gomes, A; Costa, D; Lima, JL (2005). “Pindolol is a potent scavenger of reactive nitrogen species”. Life Sciences 77 (16):  1983–1992. doi:10.1016/j.lfs.2005.02.018. PMID 15916777.
↑  Safarinejad, MR (2008). “Once-daily high-dose pindolol for paroxetine-refractory premature ejaculation: a double-blind, placebo-controlled and randomized study.”. Journal of Clinical Psychopharmacology 28 (1):  39–44. doi:10.1097/jcp.0b013e31816073a5. PMID 18204339.